Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
RedHill Biopharma Ltd. has announced the signing of a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s ...
read more
Wednesday, October 14, 2020
RedHill announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib.
read more
RedHill Biopharma has replaced its existing co-commercialization agreement with Daiichi Sankyo, for Movantik, which was assigned to RedHill under its April 2020 acquisition agreement with AstraZeneca.
read more
Thursday, November 08, 2012
Following the launch of research, pharmaceutical development and manufacturing company Almac’s new recycling initiative in May 2012, the amount of recycled waste at Almac dramatically increased from 19% to 70% in just a couple of months, and has ...
read more
Recursion, a clinical stage TechBio company decoding biology to industrialize drug discovery, launched Valence Labs which will serve as a machine learning research laboratory focused on developing the next generation of cutting-edge methods and ...
read more
Wednesday, January 26, 2022
Recro Pharma has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government. The contract focuses on supporting clinical development of a topical dermal treatment for the ...
read more
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ...
read more
Thursday, February 24, 2022
Recro Pharma reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings. All construction and equipment installation related to this service expansion has been completed at the company’s San Diego...
read more
Recro Pharma announced its CDMO division, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.
read more
Recro Gainesville has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team.
read more
Monday, November 05, 2018
Recro Gainesville has added a 24,000-square-foot facility near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant.
read more
Additional contract broadens and further strengthens customer product portfolio.
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced that it has expanded the clinical ...
read more
Recro Pharma, Inc. announces the signing of a new development agreement with Astex Pharmaceuticals, Inc.
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more